Identification of a potential molecular diagnostic biomarker in keloid disease: SYNDECAN-1 (CD138) is overexpressed in keloid scar tissue.
Name:
PIIS0022202X16321017.pdf
Size:
1.301Mb
Format:
PDF
Description:
Open access full text article
Affiliation
Plastic & Reconstructive Surgery Research, University of Manchester, Manchester, UKIssue Date
2016-07-13
Metadata
Show full item recordCitation
Identification of a potential molecular diagnostic biomarker in keloid disease: SYNDECAN-1 (CD138) is overexpressed in keloid scar tissue. 2016: J. Invest. Dermatol.Journal
The Journal of Investigative DermatologyDOI
10.1016/j.jid.2016.06.623PubMed ID
27424317Type
ArticleLanguage
enISSN
1523-1747ae974a485f413a2113503eed53cd6c53
10.1016/j.jid.2016.06.623
Scopus Count
Collections
Related articles
- Differential and exclusive diagnosis of diseases that resemble keloids and hypertrophic scars.
- Authors: Ogawa R, Akaishi S, Hyakusoku H
- Issue date: 2009 Jun
- [Keloid or Hypertrophic scar?].
- Authors: Rintala AE
- Issue date: 1996
- Identification of biomarkers involved in differential profiling of hypertrophic and keloid scars versus normal skin.
- Authors: Suarez E, Syed F, Alonso-Rasgado T, Bayat A
- Issue date: 2015 Mar
- Treatment of hypertrophic scars and keloids.
- Authors: Kaartinen I
- Issue date: 2016
- [Keloid scars of the head and neck].
- Authors: Beogo R, Guiébré YM, Sérémé M, Ouoba K, Zwetyenga N
- Issue date: 2012 Jun